Log in

Sarepta Therapeutics SEC Filings & 10K Form (NASDAQ:SRPT)

$125.42
+0.39 (+0.31 %)
(As of 02/18/2020 04:16 AM ET)
Today's Range
$123.28
Now: $125.42
$125.83
50-Day Range
$111.62
MA: $123.65
$131.64
52-Week Range
$72.05
Now: $125.42
$158.80
Volume409,759 shs
Average Volume742,044 shs
Market Capitalization$9.35 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.2

SEC Filings

Sarepta Therapeutics (NASDAQ:SRPT) SEC Filings

DateFilerForm TypeView
02/10/2020
6:32 AM
BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
01/21/2020
7:00 PM
MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2020
11:31 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:41 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
7:00 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:02 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:01 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:00 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
6:59 PM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
7:01 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:25 PM
Sarepta Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/20/2019
7:34 PM
Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:32 PM
Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
3:03 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2019
7:40 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
7:00 AM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
4:17 PM
Sarepta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/09/2019
1:18 PM
BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
1:13 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:20 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
4:43 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2019
3:33 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
3:38 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
4:48 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:22 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:02 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/07/2019
4:00 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
7:07 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
7:03 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:02 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
3:39 PM
Sarepta Therapeutics (Filer)
Form DEFA14A
04/26/2019
3:22 PM
Sarepta Therapeutics (Filer)
Form DEF 14A
04/05/2019
7:30 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2019
7:01 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
7:00 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
6:59 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2019
7:38 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
4:16 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
7:30 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
7:00 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
8:12 AM
Sarepta Therapeutics (Filer)
Form 424B5
03/07/2019
8:00 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
7:09 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:08 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:07 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:06 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:05 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:05 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:04 PM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:03 PM
BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:02 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
7:01 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
6:38 AM
Sarepta Therapeutics (Filer)
Form S-3ASR
02/28/2019
6:07 AM
Sarepta Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
12:48 PM
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G
02/14/2019
12:41 PM
Sarepta Therapeutics (Subject)
SUSQUEHANNA SECURITIES (Filed by)
Form SC 13G/A
02/14/2019
7:44 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
8:48 AM
Sarepta Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
7:02 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
4:27 PM
BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
02/01/2019
7:27 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
7:25 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
7:24 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
9:59 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
7:55 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
7:42 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
7:38 AM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
7:37 AM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2018
4:02 PM
Sarepta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/09/2018
4:15 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
4:12 PM
Sarepta Therapeutics (Filer)
Form 424B5
11/09/2018
3:41 PM
Sarepta Therapeutics (Filer)
Form CT ORDER
11/08/2018
5:09 AM
Sarepta Therapeutics (Filer)
Form 424B5
11/02/2018
5:01 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2018
5:00 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2018
3:24 PM
Sarepta Therapeutics (Filer)
Form 10-Q/A
10/31/2018
3:04 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
6:05 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2018
5:43 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2018
3:13 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
4:18 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
6:05 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
5:40 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2018
6:30 AM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
5:16 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
5:14 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
5:14 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
3:36 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2018
4:10 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2018
5:01 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
5:05 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2018
5:01 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2018
4:24 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2018
4:16 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
9:41 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
5:11 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
5:09 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2018
3:45 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2018
5:06 PM
Ruff Shamim (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
5:05 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel